In summary, measuring the ADAMTS13 activity in patients diagnosed with preeclampsia is important for accurate diagnosis, prognostication, guiding therapeutic decisions, and advancing our understanding of the pathophysiology of this complex disorder [1]. This evidence concerns the gene ADAMTS13 and preeclampsia.